Revision of Axovant Sciences
mediawikibotCreated by auto-bot V1Rendered
Sio Gene Therapies, formerly known as Axovant Gene Therapies, is a clinical-stage pharmaceutical company that develops gene therapies to treat neurological disorders. The company is headquartered in New York City and is incorporated in Basel, Switzerland. from Wikipedia
clinical-stage biopharmaceutical company
Wikitext diff vs parent
{{DISPLAYTITLE:Axovant Sciences}}Sio Gene Therapies, formerly known as Axovant Gene Therapies, is a clinical-stage pharmaceutical company that develops gene therapies to treat neurological disorders.<small> from [https://en.wikipedia.org/wiki/Axovant_Sciences Wikipedia]</small>{||+|-! Icon !! Service !! Username !!Sio Gene Therapies, formerly known as Axovant Gene Therapies, is a clinical-stage pharmaceutical company that develops gene therapies to treat neurological disorders. The company is headquartered in New York City and is incorporated in Basel, Switzerland.<small> from [https://en.wikipedia.org/wiki/Axovant_Sciences Wikipedia]</small> {{SF| {{Twt|axovant}}{{Wb|http://axovant.com/|http:axovant.com}}|}{{Wb|http://axovant.com/|axovant.com}} {{Fb|axovant}} }} {{IDF| {{Wd|Q20311716}} }}[[VHID]]:[https://verifiedhandles.com/vhid/95023244515 95023244515]{{#subtitle: <big>clinical-stage biopharmaceutical company</big>}}{{VHID|95023244515}}{{#subtitle: <big>clinical-stage biopharmaceutical company</big>}}